SAFETY OF FIRST-LINE BEVACIZUMAB (BV) PLUS CHEMOTHERAPY IN ELDERLY PATIENTS (PTS) WITH ADVANCED OR RECURRENT NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC): MO19390 (SAIL) STUDY GROUP
ANNALS OF ONCOLOGY（2008）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要